MGNX – Macrogenics Inc
Float Short %
6.48
Margin Of Safety %
Put/Call OI Ratio
0.18
EPS Next Q Diff
0.42
EPS Last/This Y
-0.64
EPS This/Next Y
-1.07
Price
1.58
Target Price
3.75
Analyst Recom
2.5
Performance Q
2.58
Relative Volume
0.52
Beta
1.62
Ticker: MGNX
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-08-15 | MGNX | 1.575 | 0.22 | 0.02 | 5205 |
| 2025-08-18 | MGNX | 1.525 | 0.32 | 0.00 | 2148 |
| 2025-08-19 | MGNX | 1.495 | 0.31 | 0.00 | 2182 |
| 2025-08-20 | MGNX | 1.49 | 0.30 | 999.99 | 2170 |
| 2025-08-21 | MGNX | 1.445 | 0.29 | 1.67 | 2168 |
| 2025-08-22 | MGNX | 1.685 | 0.30 | 0.00 | 2184 |
| 2025-08-25 | MGNX | 1.645 | 0.28 | 0.02 | 2291 |
| 2025-08-26 | MGNX | 1.81 | 0.25 | 0.04 | 2546 |
| 2025-08-27 | MGNX | 1.725 | 0.23 | 0.02 | 2753 |
| 2025-08-28 | MGNX | 1.71 | 0.23 | 0.00 | 2816 |
| 2025-08-29 | MGNX | 1.785 | 0.19 | 0.00 | 3229 |
| 2025-09-02 | MGNX | 1.735 | 0.19 | 0.00 | 3275 |
| 2025-09-03 | MGNX | 1.92 | 0.19 | 0.02 | 3296 |
| 2025-09-04 | MGNX | 1.935 | 0.18 | 0.00 | 3375 |
| 2025-09-05 | MGNX | 2 | 0.17 | 0.15 | 3540 |
| 2025-09-08 | MGNX | 1.75 | 0.18 | 0.01 | 3776 |
| 2025-09-09 | MGNX | 1.73 | 0.17 | 0.00 | 3937 |
| 2025-09-10 | MGNX | 1.715 | 0.17 | 3.00 | 3941 |
| 2025-09-11 | MGNX | 1.67 | 0.18 | 0.00 | 3946 |
| 2025-09-12 | MGNX | 1.58 | 0.18 | 0.16 | 3947 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-08-15 | MGNX | 1.57 | 142.7 | - | -0.63 |
| 2025-08-18 | MGNX | 1.52 | 142.7 | - | -0.63 |
| 2025-08-19 | MGNX | 1.49 | 142.7 | - | -0.63 |
| 2025-08-20 | MGNX | 1.49 | 142.7 | - | -0.63 |
| 2025-08-21 | MGNX | 1.44 | 142.7 | - | -0.63 |
| 2025-08-22 | MGNX | 1.69 | -136.7 | - | -1.71 |
| 2025-08-25 | MGNX | 1.65 | -136.7 | - | -1.71 |
| 2025-08-26 | MGNX | 1.81 | -136.7 | - | -1.71 |
| 2025-08-28 | MGNX | 1.70 | -136.7 | - | -1.71 |
| 2025-08-29 | MGNX | 1.79 | -136.7 | - | -1.71 |
| 2025-09-02 | MGNX | 1.73 | -136.7 | - | -1.71 |
| 2025-09-03 | MGNX | 1.92 | -136.7 | - | -1.71 |
| 2025-09-04 | MGNX | 1.94 | -136.7 | - | -1.71 |
| 2025-09-05 | MGNX | 2.00 | -136.7 | - | -1.71 |
| 2025-09-08 | MGNX | 1.76 | -136.7 | - | -1.71 |
| 2025-09-09 | MGNX | 1.72 | -136.7 | - | -1.71 |
| 2025-09-10 | MGNX | 1.72 | -136.7 | - | -1.71 |
| 2025-09-11 | MGNX | 1.65 | -136.7 | - | -1.71 |
| 2025-09-12 | MGNX | 1.58 | -136.7 | - | -1.71 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-08-15 | MGNX | -0.01 | -12.42 | 6.98 |
| 2025-08-18 | MGNX | -0.01 | -19.75 | 6.97 |
| 2025-08-19 | MGNX | -0.01 | -19.75 | 6.60 |
| 2025-08-20 | MGNX | 0.00 | -19.75 | 6.60 |
| 2025-08-21 | MGNX | 5.38 | -19.75 | 6.95 |
| 2025-08-22 | MGNX | 2.02 | -19.75 | 6.95 |
| 2025-08-25 | MGNX | 2.02 | -12.34 | 6.95 |
| 2025-08-26 | MGNX | 2.02 | -12.34 | 6.97 |
| 2025-08-27 | MGNX | 2.02 | -12.34 | 6.72 |
| 2025-08-28 | MGNX | 1.98 | -12.34 | 6.72 |
| 2025-08-29 | MGNX | 1.98 | -12.34 | 6.72 |
| 2025-09-02 | MGNX | 1.98 | -12.39 | 6.72 |
| 2025-09-03 | MGNX | 1.98 | -12.39 | 6.72 |
| 2025-09-04 | MGNX | 1.98 | -12.39 | 6.72 |
| 2025-09-05 | MGNX | 1.98 | -12.39 | 6.72 |
| 2025-09-08 | MGNX | 1.98 | -12.39 | 6.72 |
| 2025-09-09 | MGNX | 1.98 | -12.39 | 6.72 |
| 2025-09-10 | MGNX | 1.98 | -12.39 | 6.72 |
| 2025-09-11 | MGNX | 1.98 | -12.39 | 6.48 |
| 2025-09-12 | MGNX | 1.98 | -12.39 | 6.48 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.57
Avg. EPS Est. Current Quarter
-0.33
Avg. EPS Est. Next Quarter
-0.15
Insider Transactions
1.98
Institutional Transactions
-12.39
Beta
1.62
Average Sales Estimate Current Quarter
28
Average Sales Estimate Next Quarter
33
Fair Value
Quality Score
38
Growth Score
47
Sentiment Score
3
Actual DrawDown %
95.7
Max Drawdown 5-Year %
-97
Target Price
3.75
P/E
Forward P/E
PEG
P/S
0.61
P/B
2.16
P/Free Cash Flow
EPS
-0.57
Average EPS Est. Cur. Y
-1.71
EPS Next Y. (Est.)
-2.78
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-21.99
Relative Volume
0.52
Return on Equity vs Sector %
-103
Return on Equity vs Industry %
-89.8
EPS 1 7Days Diff
EPS 1 30Days Diff
0.05
EBIT Estimation
MacroGenics, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 341
MacroGenics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics to treat cancer in the United States. The company's product pipeline includes lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4 for the treatment of mCRPC and docetaxel that is in phase 2 clinical trials, as well as for the treatment of platinum-resistant ovarian cancer and clear cell gynecologic cancer which has completed phase 1 clinical trial; MGC026, an ADC that targets B7-H3 and delivers a novel topoisomerase I inhibitor (TOP1i)-based linker-payload; MGC028, an antibody-drug conjugates (ADC) that targets ADAM9 and delivers a novel TOP1i-based linker-payload for the treatment of solid tumors, which is in phase 1 clinical trials; MGC030, a ADC molecule for the treatment of solid tumors, which is in preclinical trials. It is also developing next generation T-cell engager programs. The company has collaborations with TerSera Therapeutics LLC; Incyte Corporation; and Gilead Sciences, Inc. MacroGenics, Inc. was incorporated in 2000 and is headquartered in Rockville, Maryland.
stock quote shares MGNX – Macrogenics Inc Stock Price stock today
news today MGNX – Macrogenics Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch MGNX – Macrogenics Inc yahoo finance google finance
stock history MGNX – Macrogenics Inc invest stock market
stock prices MGNX premarket after hours
ticker MGNX fair value insiders trading